PepsiCo, Inc. (PEP): what the price requires

The current priced-in claim for PepsiCo, Inc. (PEP) is temporarily suppressed because the live engine record is unavailable. The dated report remains a snapshot, not a current market read.

Generated: 2026-07-14 · Source: https://boothcheck.com/report/PEP

Headline

FieldValue
TickerPEP
CompanyPepsiCo, Inc.
Current price$138.30/sh
CompositionPFNA 29% / PBNA 30% / IB Franchise 5% / EMEA 19% / LatAm Foods 11% / Asia Pacific Foods 5%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin today13.3%
Multiple paid19x operating income

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 6.5% cost of capital with 4% terminal growth over a 5-year stage.

Reconcile: at the x-ray's 9.3% required return this reads ~15.3%/yr; the models below use their own rates.

How unusual the bet is: within-range

ReferenceValue
vs own history-1.16σ
cohort percentile (of 69 peers)54
implied end-window share0%

Valuation X-Ray

The price is justified by relative-multiple and growth-DCF; asset-based/earnings-power land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset2.01x5expensive
Earnings1.98x5expensive
Relative0.99x5justifies
Growth1.10x4expensive

Families that justify the price: Relative, Growth Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.9%); the inversion above states its own rate.

Per-Model Detail (n=19)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$135.941.02xyesFCF base $8.8B, growth 4% (input: historical growth), terminal g 4.0%, WACC 8.9%, 5yr projection
DCF Exit MultipleGrowth$136.841.01xyesExit EV/EBITDA: 10.1x / 12.1x / 14.1x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelative$153.110.90xyesP/E 22x (static sector reference · 2026-04), scenarios: 18.4x / 22.0x / 25.6x (bear / base = reference held flat / bull), EV/EBITDA 14x
Simple DDMGrowth——no—
Two-Stage DDMGrowth$116.161.19xyesStage 1: 6% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$68.862.01xyesBV/sh $15.60, ROE (TTM) 40.8%, ke 9.3%
Two-Stage Excess ReturnAsset$162.020.85xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$106.471.30xyesRev $95.4B, growth 4% (input: historical growth; tapered), Terminal P/S: 1.7x / 2.0x / 2.3x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$76.441.81xyesEPS $6.37, growth 6% (input: historical EPS growth), PEG=3.48 (Overvalued)
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings$87.841.57xyesNormalized EBIT (5y avg op income, one-time charges added back) $13.22B × (1−21%) / WACC 8.9% → EPV (no growth)
Residual IncomeAsset$109.281.27xyesBV $15.60 + 5yr PV of (ROE (TTM) 40.8% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAsset$47.282.93xyes√(22.5 × EPS $6.37 × BVPS $15.60) — Graham's conservative floor
EV/EBITDA RelativeRelative$159.910.86xyesEBITDA $15.64B × sector EV/EBITDA 14.0x
FCF YieldEarnings$69.961.98xyesFCF $8842.0M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$67.562.05xyesSBC-adj FCF $8.54B (FCF $8.84B − SBC $0.30B) capitalized at Kₑ
Ben Graham FormulaEarnings$111.961.24xyesEPS $6.37 × (8.5 + 2×6.2%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$21.056.57xyesBV $15.60 × (ROIC 12.0% / WACC 8.9%)
P/Sales SectorRelative$139.240.99xyesRevenue $95.45B × sector P/S 2.0x
PEG Fair ValueRelative$59.582.32xyesEPS $6.37 × (PEG 1.5 × growth 6.2% (input: historical EPS growth)) → PE 9.4x
Earnings YieldEarnings$68.862.01xyesEPS $6.37 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Net debt$45.7b
Net debt / NOPAT (after-tax)5.20x
Net debt / operating income (pre-tax)4.09x
Interest coverage10.2x
Share count CAGR (buyback)-0.4%
Burning cashno

Bullet Takeaways

Bull Case

The bull case for PepsiCo is increasingly a capital-allocation case, because the operating business is sound and the question is what management does with it. The company throws off enormous cash, free cash flow of about $8.8 billion on revenue near $95 billion, and earns a return on equity above 40%. Historically it has deployed that cash on dividends, a slowly shrinking share count, and reinvestment in its brands. What changed in late 2025 is that an activist with a roughly $4 billion stake arrived to argue PepsiCo could do considerably more with the same assets.

The specific lever is the beverage side. Unlike most of its peers, PepsiCo owns much of its own North American bottling, which is capital-intensive and lower-margin than the concentrate business sitting on top of it. Elliott's central proposal is to refranchise or spin off that bottling network, which would lighten the capital base and lift consolidated margins toward the asset-light model that the snacks business already runs. Management has responded with a North American supply chain review, a productivity program targeting $1.5 billion in annual savings by 2028, and a plan to cut nearly 20% of product offerings to focus on the highest-velocity SKUs. Each of those is margin self-help that does not require the categories to grow faster.

Meanwhile the core is already showing signs of stabilizing. The Frito-Lay business, the company's profit engine, returned to volume growth, with North America Foods volume up about 2% in Q1 2026 after the company restaged its flagship snack brands and cut prices to rebuild shelf presence. The 10-K frames the strategic task plainly: success depends on responding to "consumer preferences and trends, including increased consumer focus on health and wellness and sustainability." PepsiCo's portfolio spans far more than salty snacks and sugared soda, and its international food businesses across Europe, Latin America, and Asia give it growth runway the mature North American categories lack. The bull case is a cash machine being prodded toward structural efficiency at exactly the moment its volume trend turns.

Bear Case

The bear case is about the cycle the categories are in, and it is a slow one. Packaged food and sugary beverages are facing a structural shift in consumer demand toward health and wellness, and the 10-K names it directly as a risk: success requires navigating "increased consumer focus on health and wellness" among shifting consumer preferences. For years PepsiCo offset soft volumes with price increases, and that worked until shoppers pushed back. The fact that the company cut prices on Lay's, Doritos, Tostitos, and Cheetos by as much as 15% to win back volume is the tell: the pricing power that carried earnings through the inflation years has limits, and reaching for volume by cutting price is a margin headwind, not a tailwind.

The valuation does not leave much room for that pressure to persist. At today's price the asset-based and earnings-power methods both read expensive. Capitalizing the company's free cash flow at the cost of capital lands well below the price, and the book-value-plus-profitability methods sit below it too. Only the peer-multiple lens and the growth-DCF methods reach the price, and they get there by assuming the modest mid-single-digit growth the company has historically delivered keeps holding. The stock trades around 22 times earnings against a sector that is no longer reliably growing volume; if the volume recovery stalls or the price cuts deepen, the multiple is the first thing to compress. This is a quality business priced as a quality business, with little discount for the category fade.

The balance sheet adds a second constraint. Net debt of roughly $45.7 billion is real, even against strong cash generation, and interest coverage around ten times is comfortable but not a fortress. The activist's preferred fix, refranchising bottling, is not free: spinning off capital-intensive operations can unlock margin but also removes earnings and complicates the integrated beverage system PepsiCo spent years building. The bear point is that the structural overhaul the bulls are excited about is also an admission that the current configuration was carrying inefficiency, and executing a portfolio simplification and a supply-chain reorganization while volumes are soft is a lot to ask of management at once. The price already credits a clean execution of all of it.

Valuation

The price is making a modest bet for a mature staples company: that PepsiCo keeps growing earnings in the mid-single digits and that its structural-efficiency program protects margins as volume slowly recovers. The inversion is striking in how undemanding it is. The price embeds essentially no operating-income growth, a slight fade against the company's own history, which means the market is not paying for acceleration; it is paying for durability. For a business earning a 40%-plus return on equity with a globally diversified portfolio, a price that assumes near-zero growth is a far cry from the optionality premiums attached to the growth names. It is a quality-at-a-fair-price profile, not a stretched one.

The methods cluster more tightly here than in most reports, which is itself the signal. The peer-multiple lens lands almost exactly at the price, valuing PepsiCo at roughly a 22x sector earnings multiple and a beverage-and-snacks enterprise multiple that sits near where it trades. The growth-DCF methods also reach the price by crediting the steady mid-single-digit cash-flow growth. Where the methods say expensive is the static, no-growth lenses: capitalizing free cash flow with no growth, or anchoring on book value and current profitability, both land well below the price. That pattern, multiple-and-growth methods reaching the price while pure earnings-power and asset methods fall short, is the standard signature of a durable compounder. The price is not a bet beyond the evidence; it is a bet that the evidence keeps repeating.

Solvency bounds the downside without being a worry. Net debt near $45.7 billion against trailing operating income is under four times, interest coverage runs about ten times, and the dividend is well covered by the roughly $8.8 billion of free cash flow. The share count has drifted down slightly, modest buyback on top of the dividend. What the buyer is underwriting is straightforward: a globally diversified snacks-and-beverage business that compounds slowly and reliably, now with an activist-driven efficiency program as the upside lever. The risk is not the balance sheet; it is whether the category volume fade is cyclical, which the recent Frito-Lay turn suggests, or structural, which the health-and-wellness shift threatens.

Catalysts

PepsiCo's Q1 2026 print showed the volume turn the bulls have been waiting for. Net revenue grew about 8.5% year over year to roughly $19.4 billion, and core EPS came in at $1.61 against a Street estimate near $1.55. The standout was Frito-Lay, where North America Foods volume grew about 2% after the company cut prices on its flagship brands and restaged them on shelf, with resets roughly half complete at the time of the call. For full-year 2026, management guided to organic revenue growth of 2% to 4% and core constant-currency EPS growth in a mid-single-digit range. The next quarterly print is the read on whether the Frito-Lay volume recovery sustains as the price cuts annualize.

The structural catalysts run through the activist. Elliott Management disclosed a roughly $4 billion stake in September 2025 and pushed PepsiCo toward refranchising its North American bottling, simplifying the brand portfolio, and divesting non-core assets. In response the company launched a North American supply chain review, a productivity program targeting $1.5 billion in annual savings by 2028, and a plan to cut nearly 20% of its product offerings. The developments to watch are any concrete decision on the bottling network and the pace of the cost-savings rollout; those are the levers that turn a steady compounder into a margin-expansion story, and they are the reason the stock has an activist-shaped tailwind it did not have a year ago.

Peer Cohorts (Per Segment, With Filing Citations)

PFNA (PepsiCo Foods North America) (reported)

PBNA (PepsiCo Beverages North America) (reported)

International Beverages Franchise (reported)

Latin America Foods (reported)

Asia Pacific Foods (reported)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

PepsiCo Q1 2026 earnings call · company and activist disclosures, 2025-2026 · Elliott Management disclosure, 2025 · Elliott Management proposals, 2025 · PepsiCo company announcements, 2025-2026 · PepsiCo Q1 2026 earnings release · PepsiCo FY2026 guidance

View the full interactive PEP report on boothcheck